Skip Menu


New Research in Treating Infantile-Onset Pompe Disease

Thanks to a new prenatal therapy protocol by Dr. Tippi MacKenzie and the UCSF Center for Maternal-Fetal Precision Medicine, a toddler Ayla has hit developmental milestones despite having a genetic disease that took her siblings' lives.

Exome Sequencing for Prenatal Diagnosis in Nonimmune Hydrops Fetalis

The cause of most fetal anomalies is not determined prenatally. Exome sequencing has transformed genetic diagnosis after birth, but its usefulness for prenatal diagnosis is still emerging. Nonimmune hydrops fetalis (NIHF), a fetal abnormality that is often lethal, has numerous genetic causes; the extent to which exome sequencing can aid in its diagnosis is unclear.

Webinar: Placenta Accreta Disorder Spectrum

New webinar from the UCSF Fetal Treatment Center: Placenta accreta spectrum disorder is a varied and increasingly common complication of pregnancy, so ob/gyns need a firm grasp of risk factors and ultrasound signs. A multidisciplinary panel of specialists from the UCSF Fetal Treatment Center explains how they handle patients to maximize outcomes, with a case-based review that illuminates their steps to evaluation and treatment.

Genetic Testing Update Webinar

New UCSF webinar with maternal-fetal medicine specialist, Mary E. Norton, MD, discussing genetic testing options, with a focus on when exome sequencing has value to families. Also, perinatologist, Teresa N. Sparks, MD, presents specifics on exome sequencing for nonimmune hydrops fetalis, caused by many single-gene disorders, plus a look at findings from her current NIHF study.

Pacific Coast Fetal Cardiology 2020

An interactive and case-based educational symposium on advances in fetal diagnosis and innovative therapeutic strategies. Sept 12-13th 2020.